Markets Catch A Break

Oil prices fall after the U.S. and Iran agree to continue talks and keep the Strait of Hormuz open.

Your Daily Dose of Market & Career Clarity

📬 Delivered to 150,000+ ambitious readers

Silver banana goes to


Get a Top Job Offer, Guaranteed (or tuition is free) | Apply Here


Market Snapshot

📉 Banana Bits

Market News

Brains, Bonds, and Barrels

It was a split tape with a clear dividing line. The Dow closed up 0.29% (+148 points) while the S&P 500 slipped 0.37% to 7,472.79 and the Nasdaq Composite dropped 1.32% to 26,166.60.

The rule of the day was simple: anything with “AI” stapled to its forehead got sold, while industrials, energy-adjacent value, and small caps threw a party
 the Russell 2000 notching a record and brushing the 3,000 mark for the first time.

The headline villain was Alphabet, down about 5% in its worst session in roughly a year and hemorrhaging an estimated $250 billion in market value. The cause wasn’t earnings or regulation but an exodus of human capital. Gemini co-lead Noam Shazeer left for OpenAI, and Nobel-winning DeepMind scientist John Jumper defected to Anthropic.

Alphabet is raising $84.75 billion in equity (up from an initial ~$80B proposal) to bankroll an AI capex bill running $180–190 billion this year, and it wasn't alone in the red: Amazon (−4.8%), Meta (−2.3%), and Microsoft (−3%) all joined the slide.

Then there was SpaceX, the market’s newest celebrity, which fell 16% for a third straight loss. Fresh off the largest IPO in history ($75 billion, $85.7 billion after the greenshoe) and a $60 billion all-stock grab of AI coding startup Cursor, the company is now selling $20 billion-plus in bonds, earmarked to refinance bridge debt and for general corporate purposes.

With only a razor-thin ~4-5% of shares in the public float, every headline swings the stock like a kettlebell, and a rock-bottom ESG grade from MSCI didn’t exactly steady the hand.

Macro, at least, gave equities some cover. U.S.-Iran negotiators left Switzerland with a 60-day "road map" and a pledge to keep the Strait of Hormuz flowing, sending WTI below $74 and Brent toward $78. 

Cheaper oil is wonderful for almost everyone
 except the inflation hawks now running the Fed. Chair Kevin Warsh's first FOMC meeting held rates at 3.5-3.75% but nudged the 2026 core PCE forecast up to 3.3%, and markets are now openly considering the once-unthinkable: a rate hike. Thursday's PCE print (June 25) is the next gut-check.

Add the Nasdaq-100’s quarterly reshuffle swapping legacy names for CoreWeave, Rocket Lab, and friends, and you get a market quietly rotating out of yesterday’s winners. Breadth was actually healthy on Monday. It just wasn’t where the cameras were pointed.

Peel Take: Monday wasn’t a tech apocalypse but a reminder that mega-cap valuations are priced for flawless execution, and “our genius just quit” is the opposite of flawless. The bullish read: money didn’t flee the market; it rotated into small caps, industrials, and the new index kids. The bearish read: the AI trade is starting to resemble an arms race where everyone spends $100B+, and nobody’s allowed to ask about the receipts. We’re not calling a top, but when one company runs a record IPO, drops $60B on a startup, and then lines up $20B in bonds, all in a single month, that's not confidence. That’s a caffeine addiction. Buckle up through Thursday.

What's Ripe

Definium Therapeutics (DFTX) 49.8%

  • Its Phase 3 "Emerge" study of DT120, an orally disintegrating tablet for major depressive disorder, hit its primary endpoint and every key secondary one. The data carried real weight: an 8.1-point placebo-adjusted improvement on the standard depression scale at week 6, with a p-value below 0.0001, statistician-speak for "this almost certainly isn't luck."

  • About 99% of side effects were mild to moderate, and the company held $373.4M in cash (as of Mar. 31, 2026), plus access to up to $120M under a credit facility, a comfortable multi-year cushion for a clinical-stage name.

  • Peel Take: Binary biotech days are the closest the market gets to a scratch-off ticket, and DFTX just hit. Set the stock aside for a second, though; a clean Phase 3 readout in depression is a genuinely meaningful result for patients, not just shareholders, and that deserves respect. The investor catch is the usual one: the science still has to clear the FDA, and "approvable" and "profitable" live in different zip codes. And one more wrinkle: after Monday's close, Definium announced a proposed public stock offering, striking while the iron's hot, but a fresh dilution headwind to watch at the open. Enjoy the pop, but remember biotech giveth and biotech taketh away, often before lunch.

Super Micro Computer (SMCI) 15.7%

  • NVIDIA unveiled its next-gen Vera Rubin platform in Hamburg and named Supermicro among multiple system builders, including Dell, HPE, and Lenovo, effectively a front-row seat to the next AI hardware cycle. GF Securities upgraded the stock from hold to buy with a $48 price target.

  • Softer oil, courtesy of the Iran de-escalation, eases the energy math on the giant data-center buildouts SMCI feeds.

  • Peel Take: SMCI is the market's mood ring for AI hardware hype; when NVIDIA sneezes, Supermicro catches either a cold or a rocket, with no in-between. Monday, it caught the rocket. Just keep two things in mind: this is the same company that gave investors accounting-related heartburn not long ago, and it recently raised $7B, diluting holders. A glowing partner announcement is fuel, not a clean bill of health. Ride it with your eyes open.

What's Rotten

SpaceX (SPCX) 16.43%

  • Third straight down day, this time after unveiling a $20B+ bond sale (to refinance bridge debt and for general corporate purposes), fresh off a record IPO ($75B, $85.7B with the greenshoe) and a $60B all-stock deal for Cursor.

  • A tiny ~4-5% public float means even modest selling sends the price flying; thin liquidity cuts both ways. MSCI handed it the lowest possible ESG rating (CCC), with a 1-out-of-10 controversies score for extra seasoning.

  • Peel Take: SpaceX is a genuinely incredible company strapped to one of the wildest tickers ever floated. When ~95% of your shares are locked up, the stock isn’t really a stock; it’s a dinghy in a big harbor, and Monday a yacht motored past. The capital-raising spree (a record IPO, a $60B startup deal, and now $20B in bonds, all in one month) is either visionary land-grabbing or a balance sheet doing parkour. Honestly, probably both. Not for the faint of heart or the thin of stomach.

Alphabet (GOOGL) 5.0%

  • Worst day in roughly a year, shedding an estimated $250B in market cap, after two marquee AI researchers walked: Noam Shazeer to OpenAI and Nobel laureate John Jumper to Anthropic.

  • The exits spotlight a brutal talent war in which rivals will pay almost anything for the right brains. Layered on top: an $84.75B equity raise and a $180–190B AI capex bill that have investors questioning the timeline to payoff.

  • Peel Take: Google has the data, the distribution, and a mountain of cash, but talent is the one asset that can quit and walk across the street, and lately it keeps doing exactly that. Losing your Gemini co-lead and a Nobel winner in the same week is a brutal look. That said, one ugly week doesn’t unwind a search-and-cloud empire; the real worry isn’t these two resumes; it’s whether the “spend whatever it takes” AI era ever shows up in the profit line. Cheap, it is not.

🧠 Technical Trip

Interview Q&A from PJT Partners

👉 Want 1-on-1 recruiting help from PJT Partners bankers & 2,000+ top mentors? Apply to WSO Academy

📚 Lesson from the Library

đŸŽ„ Financial Planning & Analysis: Drive Better Business Decisions

Master budgeting, forecasting, and financial analysis to drive smarter business decisions.

🩈 Deal Dispatch

M&A, IPOs, And Other Notable Transactions

📊The Daily Poll

Alphabet, Amazon, Meta, and Microsoft all fell. Which Big Tech company would you be most likely to invest in today?

Login or Subscribe to participate in polls.

Previous Poll:

Emerging-market stocks hit record highs. Have you ever invested outside your home country?

Yes, regularly: 23.3% // A little: 33.4% // Not yet, but interested: 23.3% // No interest: 20.0%

Student Success Corner

👉 Are you next? Find out with WSO Academy

Banana Brain Teaser

Previous

If y is the smallest positive integer such that 3,150 multiplied by y is the square of an integer, then y must be?

Answer: 14

Today

In a small snack shop, the average (arithmetic mean) revenue was $400 per day over a 10-day period. During this period, if the average daily revenue was $360 for the first 6 days, what was the average daily revenue for the last 4 days?

❝

I’d be a bum on the street with a tin cup if the markets were always efficient.

Warren Buffet

How Would You Rate Today's Peel?


Happy Investing,
Chris, Ankit, Mitchell, Fernanda, Nick, & Patrick